EVE Health Group Ltd (ASX: EVE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
EVE Health Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$5.98 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
284.88 million
Earnings per share
-0.011
Dividend per share
N/A
Year To Date Return
-4.76%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
EVE Health Group Ltd (ASX: EVE)
Latest News
No posts found.
EVE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About EVE Health Group Ltd
EVE Health Group Ltd. engages in the development and provision of health and wellness solutions. Its portfolio includes Omni Innovation, Meluka Australia, Jenbrook Australia, and Naturally Australian Products. It operates through the following segments: Jenbrook, Meluka, and Investment. The company was founded on October 1, 2003 and is headquartered in Subiaco, Australia.
EVE Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Feb 2026 | $0.02 | $0.00 | 0.00% | 398,150 | $0.02 | $0.02 | $0.02 |
| 10 Feb 2026 | $0.02 | $0.00 | 0.00% | 769,721 | $0.02 | $0.02 | $0.02 |
| 09 Feb 2026 | $0.02 | $0.00 | 0.00% | 1 | $0.02 | $0.02 | $0.02 |
| 06 Feb 2026 | $0.02 | $0.00 | 0.00% | 26,250 | $0.02 | $0.02 | $0.02 |
| 05 Feb 2026 | $0.02 | $0.00 | 0.00% | 517,512 | $0.02 | $0.02 | $0.02 |
| 04 Feb 2026 | $0.02 | $0.00 | 0.00% | 541,068 | $0.02 | $0.02 | $0.02 |
| 03 Feb 2026 | $0.02 | $0.00 | 0.00% | 57,973 | $0.02 | $0.02 | $0.02 |
| 02 Feb 2026 | $0.02 | $0.00 | 0.00% | 349,189 | $0.02 | $0.02 | $0.02 |
| 30 Jan 2026 | $0.02 | $0.00 | 0.00% | 612,265 | $0.02 | $0.02 | $0.02 |
| 29 Jan 2026 | $0.02 | $0.00 | 0.00% | 468,817 | $0.02 | $0.02 | $0.02 |
| 28 Jan 2026 | $0.02 | $0.00 | 0.00% | 146,585 | $0.02 | $0.02 | $0.02 |
| 27 Jan 2026 | $0.02 | $0.00 | 0.00% | 1,217,271 | $0.02 | $0.02 | $0.02 |
| 23 Jan 2026 | $0.02 | $0.00 | 0.00% | 831,844 | $0.02 | $0.02 | $0.02 |
| 22 Jan 2026 | $0.02 | $0.00 | 0.00% | 476,512 | $0.02 | $0.02 | $0.02 |
| 21 Jan 2026 | $0.02 | $0.00 | 0.00% | 47,725 | $0.02 | $0.02 | $0.02 |
| 19 Jan 2026 | $0.02 | $0.00 | 0.00% | 84,908 | $0.02 | $0.02 | $0.02 |
| 16 Jan 2026 | $0.02 | $0.00 | 0.00% | 43,472 | $0.02 | $0.02 | $0.02 |
| 15 Jan 2026 | $0.02 | $0.00 | 0.00% | 631,580 | $0.02 | $0.02 | $0.02 |
| 14 Jan 2026 | $0.02 | $0.00 | 0.00% | 54,607 | $0.02 | $0.02 | $0.02 |
| 13 Jan 2026 | $0.02 | $0.00 | 0.00% | 160,797 | $0.02 | $0.02 | $0.02 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 02 Jan 2026 | Stuart Gunzburg | Buy | 200,000 | $4,200 |
On-market trade.
|
| 15 Dec 2025 | Stuart Gunzburg | Buy | 125,000 | $3,000 |
On-market trade.
|
| 05 Dec 2025 | Stuart Gunzburg | Issued | 1,000,000 | $25,000 |
Issue of options.
|
| 05 Dec 2025 | Gregory Fry | Issued | 150,000 | $3,750 |
Issue of options.
|
| 05 Dec 2025 | Rodney Hannington | Issued | 150,000 | $3,750 |
Issue of options.
|
| 21 Nov 2025 | Stuart Gunzburg | Transfer | 20,502,645 | $492,063 |
Off-market transfer.
|
| 17 Jun 2025 | Stuart Gunzburg | Buy | 279,482 | $8,963 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Stuart Gunzburg | Non-Executive Director | Jun 2025 |
Dr Gunzburg has a background in medical research and biotechnology commercialisation. At EVE Health Group, he leads the scientific and clinical development of the company's pharmaceutical pipeline, focusing on solubility enhancement and advanced drug delivery technologies. He has been involved in a number of start-up ventures across sectors including anti-cancer drug development, renewable fuels, waste management systems, and explosives technology.
|
| Mr Gregory William (Bill) Fry | Executive DirectorChief Executive OfficerManaging Director | Aug 2009 |
Mr Fry has more than 20 years of corporate experience specialising in accounting, management, business development, and general corporate activities. He has experience in project evaluation and development, project funding, management, finance, and operations. He has served on the board of several public and private companies across agriculture, mining, property, and funds management.
|
| Mr Rodney Andrew Hannington | Non-Executive ChairmanNon-Executive Director | Jun 2022 |
Mr Hannington has worked in marketing and strategy services in consumer health and fast-moving consumer goods in the Asia Pacific region for over 15 years. He has international experience in markets across Australia, China, Japan, South Korea, and Southeast Asia. He has been a member of the Monash University Department of Marketing Industry Advisory Board since 2013 and has held various board roles at ASX-listed companies, with a focus on the consumer health sector.
|
| Mr Steven Jackson | Company Secretary |
-
|
|
| Ben Rohr | Chief Operating Officer |
-
|
|
| Steven Jackson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Dr Stuart Gunzburg | 47,813,226 | 19.42% |
| Everhoney Biotech Australia Pty Ltd | 16,513,069 | 6.71% |
| Catherine Elizabeth Wood | 15,873,016 | 6.45% |
| Hong Kong Jusheng Bolang Technology Co Limited | 12,687,216 | 5.15% |
| Lcbk Pty Ltd | 7,936,508 | 3.22% |
| Mr Alasdair Cooke (And Associated Entities) | 7,366,978 | 2.99% |
| Nicole Suzanne Bartleet | 7,275,132 | 2.95% |
| Mr Marc John Calokerinos | 5,295,828 | 2.15% |
| Mr Honghao Sun | 4,766,712 | 1.94% |
| Tlc Howe Pty Ltd | 3,788,250 | 1.54% |
| Terra Metallica Nominees Pty Ltd | 3,400,000 | 1.38% |
| Mr Gregory Fry | 3,309,123 | 1.34% |
| Mr Benedict Rohr | 3,097,500 | 1.26% |
| 10 Bolivianos Pty Ltd | 2,331,147 | 0.95% |
| Mr Adam Christopher Mackie | 2,100,000 | 0.85% |
| 10 Bolivianos Pty Ltd (i) | 1,984,127 | 0.81% |
| On-Ramp Pty Ltd | 1,984,127 | 0.81% |
| Mrs Jennifer Lynette Corso | 1,725,000 | 0.70% |
| Akj Super Pty Ltd | 1,500,000 | 0.61% |
| Mr Miroslav Michael Petrovic | 1,408,334 | 0.57% |
